You have 9 free searches left this month | for more free features.

Condition

COVID19 (1)

Shock, Septic (1)

Overall Status

Active, not recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (1)

phase 2/phase 3 (1)

Sponsor

Inotrem (2)

Collaborator

Intervention

placebo (2)

nangibotide (1)

nangibotide high dose (1)

nangibotide low dose (1)

Study Documents

Intervention Type

drug (2)

Funder Type

Industry (2)

Study Type

Interventional (2)

Nangibotide

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Shock, Septic Trial in Worldwide (nangibotide low dose, nangibotide high dose, )

Active, not recruiting

Shock, Septic

nangibotide low dose
+2 more

Bruxelles, Belgium
+42 more

Sep 19, 2022

COVID19 Trial in Belgium, France (nangibotide, )

Recruiting

COVID19

nangibotide
placebo

Brussels, Belgium
+16 more

Jul 5, 2021